Conditions: Carotid Artery Disease
Keywords: CE-U/S - Contrast-Enhanced U/S U/S - Ultrasound Assess effectiveness
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 21
Healthy volunteers: no

Brief summary:
The purpose of this study is to find the optimal dose from 3 different dose levels - 0.15 mL, 0.5 mL and 1.5 mL of Optison in assessing the presence of disease of the carotid arteries when comparing pre-contrast to post-contrast ultrasound (U/S) by dose group.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Optison
Intervention descriptions: intervention 1: Optison is a sterile non-pyrogenic suspension of perflutren for IV administration.

Protocol document: